絞り込み

17703

広告

Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink.

著者 Morley J , Moayyeri A , Ali L , Taylor A , Feudjo-Tepie M , Hamilton L , Bayly J
Osteoporos Int.2019 Nov 22 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (28view , 0users)

Full Text Sources

Gaining full benefits from osteoporosis medications requires long-term treatment. Investigating the real-world persistence of women receiving osteoporosis medications in the UK, we found that most patients stop treatment within a year. To prevent osteoporotic fragility fractures, long-term treatment persistence must be improved.
PMID: 31758206 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード